Literature DB >> 11410878

Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas.

I R Bukholm1, G Bukholm, J M Nesland.   

Abstract

Progression through the mammalian cell cycle is facilitated by cyclin-cyclin-dependent kinase (cdk) complexes, which are activated at specific points during the cell cycle. Alteration in cyclin-cdk complexess may lead to altered cell cycle and tumorigenesis. In this study, we analyzed expression of cyclins A, D1, D3 and E in tumor tissue from 170 patients with primary invasive breast carcinomas. Immunohistochemical methods were used to detect protein expression of these cyclins. We detected positive immunoreactivity in 55 (32%), 22 (13%), 38 (22%) and 37 (21.8%) of the samples for cyclins A, D1, D3 and E, respectively. A highly statistically significant association was observed between expression of cyclin A and early relapse (p = 0.001 univariate analysis, p = 0.006 multivariate analysis) as well as cancer-specific death (p < 0.0001) during the follow-up time. No association was observed between cyclin D1 or cyclin E, respectively, and relapse of disease or survival, while cyclin D3 over-expression was associated with development of metastases during follow-up (p = 0.005 univariate analysis, p = 0.01 multivariate analysis). However, cyclin D3 did not show any statistically significant association when cancer-specific death was examined in a multivariate analysis (Cox regression for survival function). Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410878     DOI: 10.1002/ijc.1311

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  33 in total

1.  Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas.

Authors:  Rolf Aamodt; Kristin Jonsdottir; Solveig Norheim Andersen; Johan Bondi; Geir Bukholm; Ida R K Bukholm
Journal:  Gastroenterol Res Pract       Date:  2009-12-15       Impact factor: 2.260

2.  Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.

Authors:  F Farabegoli; C Ceccarelli; D Santini; M Taffurelli
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

3.  Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity.

Authors:  Maggie C Louie; Alexey S Revenko; June X Zou; Jennifer Yao; Hong-Wu Chen
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

4.  RPF151, a novel capsaicin-like analogue: in vitro studies and in vivo preclinical antitumor evaluation in a breast cancer model.

Authors:  Adilson Kleber Ferreira; Maurício Temotheo Tavares; Kerly Fernanda Mesquita Pasqualoto; Ricardo Alexandre de Azevedo; Sarah Fernandes Teixeira; Wilson Alves Ferreira-Junior; Ariane Matiello Bertin; Paulo Luiz de-Sá-Junior; José Alexandre Marzagão Barbuto; Carlos Rogério Figueiredo; Yara Cury; Mariana Celestina Frojuello Costa Bernstorff Damião; Roberto Parise-Filho
Journal:  Tumour Biol       Date:  2015-04-20

5.  Correlation between the protein expression of A-kinase anchor protein 95, cyclin D3 and AKT and pathological indicators in lung cancer tissues.

Authors:  Xiuyi Yu; Yangyang Yuan; Xuehong Zhi; Bogang Teng; Xiaoxuan Chen; Qian Huang; Yuexin Chen; Zhiyu Guan; Yongxing Zhang
Journal:  Exp Ther Med       Date:  2015-07-15       Impact factor: 2.447

6.  Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis.

Authors:  Lakshmi Gopinathan; Shawn Lu Wen Tan; V C Padmakumar; Vincenzo Coppola; Lino Tessarollo; Philipp Kaldis
Journal:  Cancer Res       Date:  2014-05-06       Impact factor: 12.701

7.  Preventing the degradation of mps1 at centrosomes is sufficient to cause centrosome reduplication in human cells.

Authors:  Christopher Kasbek; Ching-Hui Yang; Adlina Mohd Yusof; Heather M Chapman; Mark Winey; Harold A Fisk
Journal:  Mol Biol Cell       Date:  2007-09-05       Impact factor: 4.138

8.  Prognostic value of cyclin E expression in breast cancer: a meta-analysis.

Authors:  Sheng Gao; Jing-Jing Ma; Cheng Lu
Journal:  Tumour Biol       Date:  2013-06-18

Review 9.  Biomolecular features of clinical relevance in breast cancer.

Authors:  Maria Grazia Daidone; Angelo Paradiso; Massimo Gion; Nadia Harbeck; Fred Sweep; Manfred Schmitt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-17       Impact factor: 9.236

Review 10.  Prognostic value of proliferation in invasive breast cancer: a review.

Authors:  P J van Diest; E van der Wall; J P A Baak
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.